Increasing diagnostic accuracy to grade dysplasia in Barrett’s esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1-Reference-Cited by-同舟云学术

Increasing diagnostic accuracy to grade dysplasia in Barrett’s esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1

Published:2016-02-29 Issue:1 Volume:11 Page:
ISSN:1746-1596
Container-title:Diagnostic Pathology
language:en
Short-container-title:Diagn Pathol

Author:

Karamchandani Dipti M.,Lehman Heather L.,Ohanessian Sara E.,Massé Julie,Welsh Patricia A.,Odze Robert D.,Goldblum John R.,Berg Arthur S.,Stairs Douglas B.

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13000-016-0473-7.pdf

Reference47 articles.

1. Millikan KW, Silverstein J, Hart V, Blair K, Bines S, Roberts J, et al. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia. Arch Surg. 1995;130(6):617–24.

2. Shaheen NJ. Advances in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2005;128(6):1554–66.

3. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142–6. doi: 10.1093/jnci/dji024 .

4. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol. 1999;154(4):965–73. doi: 10.1016/S0002-9440(10)65346-1 .

5. Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, et al. Risk factors for progression of low-grade dysplasia in patients with Barrett’s esophagus. Gastroenterology. 2011;141(4):1179–86. doi: 10.1053/j.gastro.2011.06.055 . 86 e1.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the expression of immunohistochemical panel of p53, CDX2, IMP3 and AMCAR in grading dysplasia of Barrett’s esophagus and predicting the progression to esophageal adenocarcinoma;Egyptian Journal of Pathology;2023

2. CRITICAL REVIEW: BARRETS OESOPHAGUS – METAPLASIA – DYSPLASIA – MALIGNANT TRANSFORMAYION PHENOTYPICAL CHARACTERISTICS AND PROGRESSION MARKERS;EXPERIMENTAL & CLINICAL MEDICINE GEORGIA;2022-01-29

3. Artificial intelligence technique in detection of early esophageal cancer;World Journal of Gastroenterology;2020-10-21

4. Pediatric Patient With Concurrent Eosinophilic Esophagitis, Erosive Reflux Esophagitis, and Barrett's Esophagus;ACG Case Reports Journal;2020-06

5. Differentiating dysplasia markers in Barrette sophagus and adenocarcinoma;Postępy Higieny i Medycyny Doświadczalnej;2019-11-14